Other leukemias of specified cell type
In Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96), chapter 2: Neoplasms
16 billable codes under C94: all are a CC; all map to HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), HCC 20 (Lung and Other Severe Cancers), HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers).A CC or MCC (major CC) is a secondary diagnosis that raises the MS-DRG payment. An HCC counts toward a Medicare Advantage patient's risk score.
Advertisements
Instructional notes
Also applies, from Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
These notes sit on C81-C96 and apply to every code under it, including C94.
Official coding guidelines
From the ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 (CMS and NCHS). Links open the PDF at the right page.
Rules for coding benign and malignant neoplasms: using the Neoplasm Table, sequencing primary and secondary sites, treatment encounters, complications, and current cancer versus personal history.
- Admission/Encounter for treatment of primary site (page 33)
- Admission/Encounter for treatment of secondary site (page 33)
- Coding and sequencing of complications (page 34)
- Primary malignancy previously excised (page 34)
- Admissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy (page 35)
- Admission/encounter to determine extent of malignancy (page 36)
- Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms (page 36)
- Admission/encounter for pain control/management (page 36)
All codes under C94
C94 can't be used on a claim. Pick a billable code below; grey headings group them.
- C94.0Acute erythroid leukemia
- C94.00Acute erythroid leukemia, not having achieved remission
- C94.01Acute erythroid leukemia, in remission
- C94.02Acute erythroid leukemia, in relapse
- C94.2Acute megakaryoblastic leukemia
- C94.20Acute megakaryoblastic leukemia not having achieved remission
- C94.21Acute megakaryoblastic leukemia, in remission
- C94.22Acute megakaryoblastic leukemia, in relapse
- C94.3Mast cell leukemia
- C94.30Mast cell leukemia not having achieved remission
- C94.31Mast cell leukemia, in remission
- C94.32Mast cell leukemia, in relapse
- C94.4Acute panmyelosis with myelofibrosis
- C94.40Acute panmyelosis with myelofibrosis not having achieved remission
- C94.41Acute panmyelosis with myelofibrosis, in remission
- C94.42Acute panmyelosis with myelofibrosis, in relapse
- C94.6Myelodysplastic disease, not elsewhere classified
- C94.8Other specified leukemias
- C94.80Other specified leukemias not having achieved remission
- C94.81Other specified leukemias, in remission
- C94.82Other specified leukemias, in relapse
C94 MS-DRGs
As the principal diagnosis, the billable codes under C94 group to these 16 MS-DRGs (v44.0). Which one applies depends on procedures performed, secondary diagnoses (CC/MCC), and the patient's age and discharge status.
- DRG 820 Lymphoma and Leukemia with Major O.R. Procedures with MCC (16 of 16 codes)
- DRG 821 Lymphoma and Leukemia with Major O.R. Procedures with CC (16 of 16 codes)
- DRG 822 Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC (16 of 16 codes)
- DRG 834 Acute Leukemia with MCC (9 of 16 codes)
- DRG 835 Acute Leukemia with CC (9 of 16 codes)
- DRG 836 Acute Leukemia without CC/MCC (9 of 16 codes)
- DRG 837 Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC (9 of 16 codes)
- DRG 838 Chemotherapy with Acute Leukemia as Secondary Diagnosis with CC or High Dose Chemotherapy Agent (9 of 16 codes)
- DRG 839 Chemotherapy with Acute Leukemia as Secondary Diagnosis without CC/MCC (9 of 16 codes)
- DRG 850 Acute Leukemia with Other Procedures (9 of 16 codes)
- DRG 823 Lymphoma and Non-Acute Leukemia with Other Procedures with MCC (7 of 16 codes)
- DRG 824 Lymphoma and Non-Acute Leukemia with Other Procedures with CC (7 of 16 codes)
- DRG 825 Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC (7 of 16 codes)
- DRG 840 Lymphoma and Non-Acute Leukemia with MCC (7 of 16 codes)
- DRG 841 Lymphoma and Non-Acute Leukemia with CC (7 of 16 codes)
- DRG 842 Lymphoma and Non-Acute Leukemia without CC/MCC (7 of 16 codes)
Other codes that refer to C94
Notes on these codes point to C94.
- D72.825 Excludes1: leukemia (C91.-, C92.-, C93.-, C94.-, C95.-)
About the condition
Plain-language background from MedlinePlus (National Library of Medicine), not coding guidance.
Leukemia
Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:
Read more about leukemia on MedlinePlusCode history
Valid since FY2016, when ICD-10-CM took effect on October 1, 2015. No changes since.
